Land: Verenigd Koninkrijk
Taal: Engels
Bron: MHRA (Medicines & Healthcare Products Regulatory Agency)
Chlorpromazine hydrochloride
Phoenix Healthcare Distribution Ltd
N05AA01
Chlorpromazine hydrochloride
50mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020100
PACKAGE LEAFLET: INFORMATION FOR THE USER CHLORPROMAZINE 25MG, 50MG, 100MGTABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU: - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Chlorpromazine Tablets are and what they are used for 2. What you need to know before you take Chlorpromazine Tablets 3. How to take Chlorpromazine Tablets 4. Possible side effects 5. How to store Chlorpromazine Tablets 6. Contents of the pack and other information 1. WHAT CHLORPROMAZINE TABLETS ARE AND WHAT THEY ARE USED FOR Chlorpromazine tablets belong to a group of drugs known as phenothiazines, which act on the central nervous system. They are used to treat the following conditions: SCHIZOPHRENIA and OTHER PSYCHOSES particularly PARANOIA (delusions and feelings of persecution), MANIA (overactive behaviour and HYPOMANIA (elated moods and excitability), ANXIETY, AGITATION and VIOLENT OR DANGEROUSLY IMPULSIVE behaviour. Chlorpromazine is also used for prolonged periods of HICCUPS, FEELING OR BEING SICK (when other drugs have failed), to LOWER BODY TEMPERATURE and for CHILDHOOD SCHIZOPHRENIA and AUTISM (learning and communication difficulties). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CHLORPROMAZINE TABLETS DO NOT TAKE CHLORPROMAZINE TABLETS AND TELL YOUR DOCTOR if you: are ALLERGIC (hypersensitive) to Chlorpromazine, other phenothiazines or to any of the other ingredients in the tablets (see Section 6). Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue have a low number of blood cells (bone Lees het volledige document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Chlorpromazine 50mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Chlorpromazine Hydrochloride 50.00 mg See 6.1 for excipients 3 PHARMACEUTICAL FORM Film-coated tablet Round, white, film-coated tablets marked ‘CPZ50’. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Schizophrenia and other psychoses (especially where paranoia is a predominant symptom), mania and hypomania. In anxiety, psychomotor agitation, excitement, violent or dangerously impulsive behaviour. Chlorpromazine may be used as an adjunct in the short-term management of these conditions. Intractable hiccup. Nausea and vomiting in terminal illness (where other drugs have failed or are not available). Induction of hypothermia is facilitated by Chlorpromazine Tablets which prevents shivering and causes vasodilatation. Childhood schizophrenia and autism. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Dosages should be low to begin with and gradually increased under close supervision until the optimum dosage for the individual is reached. Individuals vary considerably and the optimum dose may be affected by the formulation used. Dosage of chlorpromazine in schizophrenia, other psychoses, anxiety and agitation etc. Adult: Initially 25 mg t.d.s. or 75 mg at bedtime increasing by daily amounts of 25 mg to an effective maintenance dose. This is usually in the range 75 to 300 mg daily but some patients may require up to 1 g daily. Children under 1 year: Do not use unless the risk-benefit ratio has been assessed. Children 1-5 years: 0.5 mg/kg body weight every 4-6 hours to a maximum recommended dose of 40 mg daily. Children 6-12 years: 1 / 3 -½ adult dose to a maximum recommended dose of 75 mg daily. Elderly or debilitated patients: Start with 1 / 3 -½ usual adult dose with a more gradual increase in dosage. Hiccups Adult: 25-50 mg t.d.s. or q.d.s. Children under 1 year: No information available. Children 1-5 years: No information available. Children 6-12 years: No information available Lees het volledige document